Biotechnology

New patent for drug Axsome AUVELITY – DrugPatentWatch

[ad_1]

Copyright © DrugPatentWatch. Originally published in New patent for the drug Axsome AUVELITY

Annual Drug Patent Expiration for AUVELITY
Annual Drug Patent Expiration for AUVELITY

Auvelity is a drug marketed by Axsome and included in one NDA. It is available from a single supplier. There are a hundred patents protecting this drug.

This drug has one hundred and forty patent family members in thirty countries.

The generic ingredient in AUVELITY is bupropion hydrochloride; dextromethorphan hydrobromide. One registered supplier for this compound. Additional details are available on bupropion hydrochloride; dextromethorphan hydrobromide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published in New patent for the drug Axsome AUVELITY

[ad_2]

Source link

Related Articles

Back to top button